P

PharmaEssentia

204 employees

PharmaEssentia develops treatments for myeloproliferative neoplasms, hepatitis, and other diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Pharmaceutical
Orphan Disease
Orphan Drugs
Drug Development
Biologics
Hematology
Rare Disease
Health Care
Oncology
Pharmaceuticals

Date founded

2003

Funding rounds raised

P

PharmaEssentia raised undisclosed on August 15, 2022

Investors: Taiwania Capital

FAQ